ALXNALEXION PHARMACEUTICALS, INC.

Nasdaq www.alexion.com


$ 183.08 $ 0.00 (0 %)    

Tuesday, 20-Jul-2021 16:07:29 EDT
QQQ $ 440.29 $ -0.17 (-0.04 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.04 $ 0.00 (0 %)
GLD $ 214.46 $ -0.24 (-0.11 %)
$ 182.5
$ 0.00 x 0
$ 0.00 x 0
-- - --
$ 99.91 - $ 187.45
3
na
40.62B
$ 0.90
$ 59.58
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-30-2021 03-31-2021 10-Q
2 02-08-2021 12-31-2020 10-K
3 10-29-2020 09-30-2020 10-Q
4 07-30-2020 06-30-2020 10-Q
5 05-06-2020 03-31-2020 10-Q
6 02-04-2020 12-31-2019 10-K
7 10-23-2019 09-30-2019 10-Q
8 07-24-2019 06-30-2019 10-Q
9 04-25-2019 03-31-2019 10-Q
10 02-06-2019 12-31-2018 10-K
11 10-24-2018 09-30-2018 10-Q
12 07-26-2018 06-30-2018 10-Q
13 04-26-2018 03-31-2018 10-Q
14 02-08-2018 12-31-2017 10-K
15 10-26-2017 09-30-2017 10-Q
16 07-27-2017 06-30-2017 10-Q
17 04-27-2017 03-31-2017 10-Q
18 02-16-2017 12-31-2016 10-K
19 01-04-2017 09-30-2016 10-Q
20 07-29-2016 06-30-2016 10-Q
21 04-29-2016 03-31-2016 10-Q
22 02-08-2016 12-31-2015 10-K
23 11-02-2015 09-30-2015 10-Q
24 07-31-2015 06-30-2015 10-Q
25 04-24-2015 03-31-2015 10-Q
26 02-06-2015 12-31-2014 10-K
27 10-24-2014 09-30-2014 10-Q
28 07-25-2014 06-30-2014 10-Q
29 04-25-2014 03-31-2014 10-Q
30 02-10-2014 12-31-2013 10-K
31 10-25-2013 09-30-2013 10-Q
32 07-26-2013 06-30-2013 10-Q
33 04-30-2013 03-31-2013 10-Q
34 02-19-2013 12-31-2012 10-K
35 10-29-2012 09-30-2012 10-Q
36 07-27-2012 06-30-2012 10-Q
37 05-02-2012 03-31-2012 10-Q
38 02-17-2012 12-31-2011 10-K
39 10-31-2011 09-30-2011 10-Q
40 08-03-2011 06-30-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 alexions-ultomiris-sales-almost-doubles-in-1h-2021-as-39b-astrazeneca-deal-looms

Ultomiris, the successor to Alexion Pharmaceuticals Inc's (NASDAQ: ALXN) paroxysmal nocturnal hemoglobinuria (PNH) drug Sol...

 moderna-options-traders-mixed-on-sp-500-inclusion

Moderna, Inc (NASDAQ: MRNA) gapped up 6.64% Friday morning after it was announced the company will join the S&P 500 beginni...

Core News & Articles

Shares of COVID-19 vaccine company Moderna, Inc. (NASDAQ: MRNA), which ended Thursday's session with a market cap of $104.3...

Core News & Articles

https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20210715-1419561/1419561_5alxn.pdf

 alexion-announces-phase-3-study-of-ultomiris-in-generalized-myasthenia-gravis-met-its-primary-endpoint

– Study met primary endpoint of change from baseline in the Myasthenia Gravis-Activities of Daily Living Profile (MG-ADL) total...

 the-daily-biotech-pulse-galapagos-sinks-on-data-jj-recalls-sunscreen-products-fibrogen-awaits-adcom-verdict-3-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

    Before 10 a.m. ET Wednesday, 81 stocks made new 52-week highs.

 the-daily-biotech-pulse-equillium-issues-positive-regulatory-update-biogen-in-licenses-multiple-sclerosis-drug-aridis-releases-covid-19-antibody-cocktail-data

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

AstraZeneca's (NYSE: AZN) proposed acquisition of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has achieved an important st...

 the-daily-biotech-pulse-iterums-regulatory-setback-decision-day-for-provention-bio-cidara--outset-medical-announce-cfo-departures

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 the-daily-biotech-pulse-sanofi-bets-big-on-mrna-tech-decision-day-for-mediwound-diamedica-issues-kidney-disease-data-readout

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

    During the morning session on Monday, 118 stocks hit new 52-week highs.

 the-daily-biotech-pulse-biogen-faces-another-clinical-setback-curevacs-covid-19-vaccine-study-fails-moment-of-reckoning-for-orphazyme

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

    Before 10 a.m. ET on Wednesday, 105 companies hit new 52-week highs.

 the-week-ahead-in-biotech-takeda-blueprint-medicines-orphazyme-eton-on-the-radar-ahead-of-fda-decisions-ipos

Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific...

Core News & Articles

    During Friday's morning session, 235 stocks hit new 52-week highs.

 the-daily-biotech-pulse-vertex-shelves-mid-stage-study-precigen--novan-jump-on-data-hematology-conference-janux-debuts

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

Core News & Articles

  Before 10 a.m. ET on Thursday, 258 companies set new 52-week highs.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION